Correction to: Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry.
作者信息
Hu Cheng, Wang Tao, Zhuang Xiaoyu, Sun Qiaoli, Wang Xiaochun, Lin Hui, Feng Mingli, Zhang Jiaqi, Cao Qin, Jiang Yuanye
机构信息
Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
Department of Gastroenterology, Putuo Hospital, Shanghai University of Traditional Chinese Medicine, 164 Lanxi Road, Shanghai, 200062, China.
出版信息
J Transl Med. 2022 Jan 10;20(1):24. doi: 10.1186/s12967-021-03223-4.
Abstract
摘要
相似文献
1
Correction to: Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry.对《使用液相色谱-质谱法对人类早期非酒精性脂肪性肝病进行代谢分析》的修正
J Transl Med. 2022 Jan 10;20(1):24. doi: 10.1186/s12967-021-03223-4.
2
Metabolic phenotyping and systems biology approaches to understanding metabolic syndrome and fatty liver disease.代谢表型和系统生物学方法研究代谢综合征和脂肪肝。
Gastroenterology. 2014 Jan;146(1):46-62. doi: 10.1053/j.gastro.2013.11.001. Epub 2013 Nov 7.
3
Liquid Extraction Surface Analysis Mass Spectrometry Method for Identifying the Presence and Severity of Nonalcoholic Fatty Liver Disease.液体萃取表面分析质谱法鉴定非酒精性脂肪性肝病的存在和严重程度。
Anal Chem. 2017 May 2;89(9):5161-5170. doi: 10.1021/acs.analchem.7b01097. Epub 2017 Apr 19.
4
Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry.使用液相色谱 - 质谱联用技术对人类早期非酒精性脂肪性肝病进行代谢分析。
J Transl Med. 2021 Apr 15;19(1):152. doi: 10.1186/s12967-021-02820-7.
5
Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.基于液相色谱-质谱联用的人源和鼠源模型血清平行代谢组学分析揭示了与非酒精性脂肪性肝病进展相关的潜在生物标志物。
J Proteome Res. 2010 Sep 3;9(9):4501-12. doi: 10.1021/pr1002593.
6
Nonalcoholic fatty liver disease is an early predictor of metabolic diseases in a metabolically healthy population.非酒精性脂肪性肝病是代谢健康人群代谢性疾病的早期预测指标。
PLoS One. 2019 Nov 4;14(11):e0224626. doi: 10.1371/journal.pone.0224626. eCollection 2019.
7
Moderation Effect of Handgrip Strength on the Associations of Obesity and Metabolic Syndrome With Fatty Liver in Adolescents.青少年手握力对肥胖和代谢综合征与脂肪肝相关性的调节作用。
J Clin Densitom. 2020 Apr-Jun;23(2):278-285. doi: 10.1016/j.jocd.2019.04.003. Epub 2019 Apr 11.
8
The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.非肥胖非糖尿病土耳其人群中胰岛素抵抗、代谢综合征与非酒精性脂肪性肝病之间的关系：一项初步研究。
Turk J Gastroenterol. 2014 Dec;25 Suppl 1:63-8. doi: 10.5152/tjg.2014.6233.
9
Distinguishing NASH Histological Severity Using a Multiplatform Metabolomics Approach.使用多平台代谢组学方法区分非酒精性脂肪性肝炎的组织学严重程度
Metabolites. 2020 Apr 24;10(4):168. doi: 10.3390/metabo10040168.
10
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.代谢综合征作为非酒精性脂肪性肝病的预测指标。
Ann Intern Med. 2005 Nov 15;143(10):722-8. doi: 10.7326/0003-4819-143-10-200511150-00009.
引用本文的文献
1
Biomarker discovery in NAFLD: insights from metabolomics and vote counting meta-analysis.非酒精性脂肪性肝病中的生物标志物发现：代谢组学与投票计数荟萃分析的见解
Metabolomics. 2025 Aug 12;21(5):116. doi: 10.1007/s11306-025-02312-5.
本文引用的文献
1
Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry.使用液相色谱 - 质谱联用技术对人类早期非酒精性脂肪性肝病进行代谢分析。
J Transl Med. 2021 Apr 15;19(1):152. doi: 10.1186/s12967-021-02820-7.
Zotero 插件